R. Alan Failor

658 total citations
19 papers, 234 citations indexed

About

R. Alan Failor is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, R. Alan Failor has authored 19 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 5 papers in Genetics. Recurrent topics in R. Alan Failor's work include Pituitary Gland Disorders and Treatments (8 papers), Adrenal and Paraganglionic Tumors (7 papers) and Glioma Diagnosis and Treatment (4 papers). R. Alan Failor is often cited by papers focused on Pituitary Gland Disorders and Treatments (8 papers), Adrenal and Paraganglionic Tumors (7 papers) and Glioma Diagnosis and Treatment (4 papers). R. Alan Failor collaborates with scholars based in United States and Russia. R. Alan Failor's co-authors include Marian T. Childs, John J. Albers, Alan Chait, David M. Foster, Edwin L. Bierman, John D. Brunzell, E L Bierman, Karen E. Friday, John D. Brunzell and B. Greg Brown and has published in prestigious journals such as Neurosurgery, American Heart Journal and Metabolism.

In The Last Decade

R. Alan Failor

17 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Alan Failor United States 7 152 112 72 39 39 19 234
Rolf V. Andersen Denmark 6 122 0.8× 149 1.3× 104 1.4× 40 1.0× 39 1.0× 8 386
Maija Ruuth Finland 10 118 0.8× 82 0.7× 29 0.4× 92 2.4× 43 1.1× 18 278
Camilla Skoglund-Andersson Sweden 7 127 0.8× 174 1.6× 63 0.9× 83 2.1× 49 1.3× 8 367
A Jadhav India 7 165 1.1× 196 1.8× 32 0.4× 70 1.8× 70 1.8× 17 368
John S. Melish United States 5 102 0.7× 160 1.4× 30 0.4× 43 1.1× 65 1.7× 11 248
H. Tineke Westerveld Netherlands 8 116 0.8× 215 1.9× 55 0.8× 23 0.6× 48 1.2× 10 316
Fumiko Tazoe Japan 7 58 0.4× 56 0.5× 37 0.5× 109 2.8× 38 1.0× 11 235
J. Hywel Thomas United Kingdom 8 86 0.6× 101 0.9× 38 0.5× 103 2.6× 12 0.3× 30 293
Steven Coon United States 15 108 0.7× 51 0.5× 75 1.0× 180 4.6× 14 0.4× 29 354
Susan McGeoch United Kingdom 7 45 0.3× 203 1.8× 50 0.7× 98 2.5× 28 0.7× 8 366

Countries citing papers authored by R. Alan Failor

Since Specialization
Citations

This map shows the geographic impact of R. Alan Failor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Alan Failor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Alan Failor more than expected).

Fields of papers citing papers by R. Alan Failor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Alan Failor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Alan Failor. The network helps show where R. Alan Failor may publish in the future.

Co-authorship network of co-authors of R. Alan Failor

This figure shows the co-authorship network connecting the top 25 collaborators of R. Alan Failor. A scholar is included among the top collaborators of R. Alan Failor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Alan Failor. R. Alan Failor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Nistal, Dominic, Luis F. Gonzalez‐Cuyar, K. Mark Weaver, et al.. (2025). Surgical Outcomes of Silent ACTH+ Corticotroph Pituitary Neuroendocrine Tumors: A Multi-Institutional Experience and Review of the Literature. Neurosurgery. 97(5). 1118–1123.
3.
Endo, Mayumi, et al.. (2023). The Incidence of Graves’ Hyperthyroidism Before and After COVID-19 Messenger RNA Vaccination. Endocrine Practice. 29(8). 618–622. 5 indexed citations
4.
Halasz, Lia M., Myron Goldberg, R. Alan Failor, et al.. (2022). Surveillance of long-term complications after treatment of adult brain tumor survivors—review and evidence-based recommendations. Neuro-Oncology Practice. 9(6). 475–486. 7 indexed citations
5.
Khot, Sandeep, et al.. (2022). Pheochromocytoma-induced Subarachnoid and Intracerebral Hemorrhage. Journal of the Endocrine Society. 7(1). bvac176–bvac176. 2 indexed citations
6.
Failor, R. Alan, et al.. (2022). ODP627 Hypercalcemia in a Patient With Gastrointestinal Stromal Tumor (GIST): Evaluation and Treatment Strategies. Journal of the Endocrine Society. 6(Supplement_1). A186–A187. 1 indexed citations
7.
Deng, Xinxian, He Fang, Whitney Neufeld‐Kaiser, et al.. (2020). Deletion of FUNDC2 and CMC4 on Chromosome Xq28 Is Sufficient to Cause Hypergonadotropic Hypogonadism in Men. Frontiers in Genetics. 11. 557341–557341. 6 indexed citations
8.
Failor, R. Alan, et al.. (2020). SUN-168 Case Series of ACTH-Secreting Pheochromocytoma: Diagnosis and Management. Journal of the Endocrine Society. 4(Supplement_1). 1 indexed citations
9.
Ruzevick, Jacob, Luis F. Gonzalez‐Cuyar, Patrick J. Cimino, et al.. (2017). Clival paragangliomas: a report of two cases involving the midline skull base and review of the literature. Journal of Neuro-Oncology. 132(3). 473–478. 5 indexed citations
10.
Hannah‐Shmouni, Fady, Andreas Moraitis, Fábio R. Faucz, et al.. (2017). Successful Treatment of Estrogen Excess in Primary Bilateral Macronodular Adrenocortical Hyperplasia with Leuprolide Acetate. Hormone and Metabolic Research. 50(2). 124–132. 8 indexed citations
11.
Ko, Andrew L., et al.. (2012). Two patients with primary sellar leiomyomas, a rare entity. Journal of Clinical Neuroscience. 20(6). 897–901. 5 indexed citations
12.
Desantis, Andrea, et al.. (2012). Endoscopic Transsphenoidal Surgery for the Treatment of Growth Hormone-Secreting Tumors Involving the Cavernous Sinus. Journal of Neurological Surgery Part B Skull Base. 73(S 02). 1 indexed citations
13.
Failor, R. Alan & Peter Capell. (2003). Hyperaldosteronism and pheochromocytoma: new tricks and tests. Primary Care Clinics in Office Practice. 30(4). 801–820. 3 indexed citations
14.
Deeb, Samir S., R. Alan Failor, B. Greg Brown, et al.. (1992). Association of apolipoprotein B gene variants with plasma apoB and low density lipoprotein (LDL) cholesterol levels. Human Genetics. 88(4). 463–470. 18 indexed citations
15.
Friday, Karen E., R. Alan Failor, Marian T. Childs, & E L Bierman. (1991). Effects of n-3 and n-6 fatty acid-enriched diets on plasma lipoproteins and apolipoproteins in heterozygous familial hypercholesterolemia.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 11(1). 47–54. 35 indexed citations
16.
Failor, R. Alan, Marian T. Childs, & Edwin L. Bierman. (1988). The effects of ω3 and ω6 fatty acid-enriched diets on plasma lipoproteins and apoproteins in familial combined hyperlipidemia. Metabolism. 37(11). 1021–1028. 43 indexed citations
17.
Brunzell, John D., Alan Chait, John J. Albers, et al.. (1987). Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity). American Heart Journal. 113(2). 583–588. 4 indexed citations
18.
Foster, David M., et al.. (1986). Evidence for kinetic heterogeneity among human low density lipoproteins. Metabolism. 35(8). 685–696. 66 indexed citations
19.
Chait, Alan, David M. Foster, John J. Albers, R. Alan Failor, & John D. Brunzell. (1986). Low density lipoprotein metabolism in familial combined hyperlipidemia and familial hypercholesterolemia: Kinetic analysis using an integrated model. Metabolism. 35(8). 697–704. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rolf V. Andersen Breakdown of academic impact, for papers by Maija Ruuth Breakdown of academic impact, for papers by Camilla Skoglund-Andersson Breakdown of academic impact, for papers by A Jadhav Breakdown of academic impact, for papers by John S. Melish Breakdown of academic impact, for papers by H. Tineke Westerveld Breakdown of academic impact, for papers by Fumiko Tazoe Breakdown of academic impact, for papers by J. Hywel Thomas Breakdown of academic impact, for papers by Steven Coon Breakdown of academic impact, for papers by Susan McGeoch
Rankless by CCL
2026